Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells
Rekha Rao, Ramesh Balusu, Warren Fiskus, Uma Mudunuru, Sreedhar Venkannagari, Lata Chauhan, Jacqueline E. Smith, Stacey L. Hembruff, Kyungsoo Ha, Peter Atadja, Kapil N. Bhalla
Dive into the research topics of 'Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells'. Together they form a unique fingerprint.